Page results
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.
-
Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
UCLH has achieved excellent results in the 2024 National Adult Inpatient Survey, with patients rating their overall care 8.4 out of 10. This gives UCLH the second highest score of London’s acute teaching hospitals.
File results
-
UCLH Private maternity brochure May 2024
-
-
-
Maternity referral form
-
Headache Service additional medication Information
-
Psychology referral form (children and young patients)
-
RLHIM Pharmacy Product Catalogue
-
Patient telephone reminder service opt-out form
-
UCLH Membership Development Strategy
-
What young people would like everyone to know about Type 1 Diabetes